Kazuo Ikeda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kazuo Ikeda has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Hayato Urushima
Osaka Metropolitan University
6 shared publications - Hideto Yuasa
Department of Anatomy and Regenerative Biology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan
5 shared publications - Atsuko Daikoku
Osaka Metropolitan University
4 shared publications - Tsutomu Matsubara
Department of Anatomy and Regenerative Biology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan
4 shared publications Chiho Kadono
Department of Anatomy and Regenerative Biology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan
3 shared publicationsKatsutoshi Yoshizato
Osaka Metropolitan University
3 shared publications
Latest Publications
- 1 February 2026
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 330  (2) , C434-C447
A hepatocyte membrane-based culture system recapitulating the physiological microenvironment of hepatic stellate cells
We developed a hepatocyte plasma membrane-based culture system that mimics in vivo cell-cell adhesion to regulate hepatic stellate cell (HSC) phenotypes. This platform maintains HSC quiescence by reducing activation markers and preserving a quiescent morphology, while allowing the observation of HSC activation in response to TGF-β treatment. It provides a physiologically relevant tool for studying HSC regulation and screening antifibrotic therapies, advancing in vitro modeling of liver fibrosis.
- 1 February 2026
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 330  (2) , C434-C447
A hepatocyte membrane-based culture system recapitulating the physiological microenvironment of hepatic stellate cells
We developed a hepatocyte plasma membrane-based culture system that mimics in vivo cell-cell adhesion to regulate hepatic stellate cell (HSC) phenotypes. This platform maintains HSC quiescence by reducing activation markers and preserving a quiescent morphology, while allowing the observation of HSC activation in response to TGF-β treatment. It provides a physiologically relevant tool for studying HSC regulation and screening antifibrotic therapies, advancing in vitro modeling of liver fibrosis.
- Open Access
- 4 September 2025
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 191, 118520
Lawsone can suppress liver fibrosis by inhibition of YAP signaling and induction of CYGB expression in hepatic stellate cells
- 4 September 2025
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 191, 118520
Open AccessLawsone can suppress liver fibrosis by inhibition of YAP signaling and induction of CYGB expression in hepatic stellate cells
- 1 March 2025
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 328  (3) , C757-C775
Cdc42 is crucial for the early regulation of hepatic stellate cell activation
The activation of hepatic stellate cells from a quiescent state is a cause and a therapeutic target for liver fibrosis. Morphological alterations in the hepatic stellate cells play a critical role in initiating their activation. However, the mechanisms that regulate these alterations remain unexplored. Our results indicate that cell division cycle 42 is a crucial regulator of hepatic stellate cell activation and a novel target for the development of therapeutic agents against liver fibrosis.
- 1 March 2025
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 328  (3) , C757-C775
Cdc42 is crucial for the early regulation of hepatic stellate cell activation
The activation of hepatic stellate cells from a quiescent state is a cause and a therapeutic target for liver fibrosis. Morphological alterations in the hepatic stellate cells play a critical role in initiating their activation. However, the mechanisms that regulate these alterations remain unexplored. Our results indicate that cell division cycle 42 is a crucial regulator of hepatic stellate cell activation and a novel target for the development of therapeutic agents against liver fibrosis.
- Open Access
- 1 December 2024
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 327  (6) , G741-G753
AHCC inhibited hepatic stellate cells activation by regulation of cytoglobin induction via TLR2-SAPK/JNK pathway and collagen production via TLR4-NF-κβ pathway
AHCC, a standardized extract of cultured Lentinula edodes mycelia, suppresses liver fibrosis progression by induction of cytoglobin via the Toll-like receptor 2 (TLR2)-stress-activated protein kinase/Jun NH2-terminal kinase (SAPK/JNK) pathway and the inhibition of collagen production via the TLR4-NFκβ pathway in hepatic stellate cells. Daily oral administration of AHCC from the stage of MASLD may have the potential to prevent disease progression to MASH with fibrosis.
- 1 December 2024
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 327  (6) , G741-G753
Open AccessAHCC inhibited hepatic stellate cells activation by regulation of cytoglobin induction via TLR2-SAPK/JNK pathway and collagen production via TLR4-NF-κβ pathway
AHCC, a standardized extract of cultured Lentinula edodes mycelia, suppresses liver fibrosis progression by induction of cytoglobin via the Toll-like receptor 2 (TLR2)-stress-activated protein kinase/Jun NH2-terminal kinase (SAPK/JNK) pathway and the inhibition of collagen production via the TLR4-NFκβ pathway in hepatic stellate cells. Daily oral administration of AHCC from the stage of MASLD may have the potential to prevent disease progression to MASH with fibrosis.
- 1 March 2023
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 324  (3) , G219-G230
Hypo-osmolarity induces apoptosis resistance via TRPV2-mediated AKT-Bcl-2 pathway
Our study first revealed that hypo-osmolarity-induced mechanotransduction enhanced calcium-mediated AKT signaling via TRPV2 activation, resulting in contributing to apoptosis resistance. The finding indicates a possible view that liver cirrhosis-induced hyponatremia promotes hepatocellular carcinogenesis.
- 1 March 2023
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 324  (3) , G219-G230
Hypo-osmolarity induces apoptosis resistance via TRPV2-mediated AKT-Bcl-2 pathway
Our study first revealed that hypo-osmolarity-induced mechanotransduction enhanced calcium-mediated AKT signaling via TRPV2 activation, resulting in contributing to apoptosis resistance. The finding indicates a possible view that liver cirrhosis-induced hyponatremia promotes hepatocellular carcinogenesis.
- Open Access
- 30 September 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8  (39) , eabo5525
Cancer cells produce liver metastasis via gap formation in sinusoidal endothelial cells through proinflammatory paracrine mechanisms
Intracellular gap (iGap) formation in liver sinusoidal endothelial cells (LSECs) is caused by the destruction of fenestrae and appears under pathological conditions; nevertheless, their role in metastasis of cancer cells to the liver remained unexplored. We elucidated that hepatotoxin-damaged and fibrotic livers gave rise to LSECs-iGap formation, which was positively correlated with increased numbers of metastatic liver foci after intrasplenic injection of Hepa1-6 cells. Hepa1-6 cells induced interleukin-23–dependent tumor necrosis factor–α (TNF-α) secretion by LSECs and triggered LSECs-iGap formation, toward which their processes protruded to transmigrate into the liver parenchyma. TNF-α triggered depolymerization of F-actin and induced matrix metalloproteinase 9 (MMP9), intracellular adhesion molecule 1, and CXCL expression in LSECs. Blocking MMP9 activity by doxycycline or an MMP2/9 inhibitor eliminated LSECs-iGap formation and attenuated liver metastasis of Hepa1-6 cells. Overall, this study revealed that cancer cells induced LSEC-iGap formation via proinflammatory paracrine mechanisms and proposed MMP9 as a favorable target for blocking cancer cell metastasis to the liver.
- 30 September 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8  (39) , eabo5525
Open AccessCancer cells produce liver metastasis via gap formation in sinusoidal endothelial cells through proinflammatory paracrine mechanisms
Intracellular gap (iGap) formation in liver sinusoidal endothelial cells (LSECs) is caused by the destruction of fenestrae and appears under pathological conditions; nevertheless, their role in metastasis of cancer cells to the liver remained unexplored. We elucidated that hepatotoxin-damaged and fibrotic livers gave rise to LSECs-iGap formation, which was positively correlated with increased numbers of metastatic liver foci after intrasplenic injection of Hepa1-6 cells. Hepa1-6 cells induced interleukin-23–dependent tumor necrosis factor–α (TNF-α) secretion by LSECs and triggered LSECs-iGap formation, toward which their processes protruded to transmigrate into the liver parenchyma. TNF-α triggered depolymerization of F-actin and induced matrix metalloproteinase 9 (MMP9), intracellular adhesion molecule 1, and CXCL expression in LSECs. Blocking MMP9 activity by doxycycline or an MMP2/9 inhibitor eliminated LSECs-iGap formation and attenuated liver metastasis of Hepa1-6 cells. Overall, this study revealed that cancer cells induced LSEC-iGap formation via proinflammatory paracrine mechanisms and proposed MMP9 as a favorable target for blocking cancer cell metastasis to the liver.
- 1 August 2010
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 63  (8) , e635-e636
Trigger finger at the A2 pulley in children – two case reports
- 1 August 2010
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 63  (8) , e635-e636
Trigger finger at the A2 pulley in children – two case reports
- Open Access
- 1 April 2010
- Published by Elsevier in Journal of Dermatological Science
- Vol. 58  (1) , 43-54
Laminin-511, inducer of hair growth, is down-regulated and its suppressor in hair growth, laminin-332 up-regulated in chemotherapy-induced alopecia
- 1 April 2010
- Published by Elsevier in Journal of Dermatological Science
- Vol. 58  (1) , 43-54
Open AccessLaminin-511, inducer of hair growth, is down-regulated and its suppressor in hair growth, laminin-332 up-regulated in chemotherapy-induced alopecia
- Open Access
- 1 August 2006
- Published by Institute of Electrical and Electronics Engineers (IEEE) in 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
- No. 1557170X,p. 5940-5943
Development of an Ambulatory Device for Monitoring Posture Change and Walking Speed for Use in Rehabilitation
Monitoring of posture change in sagittal plane and walking speed is important for evaluate the effectiveness of rehabilitation program or brace. We have developed a wearable device for monitoring human activity. However, in the previous system, there still remain several drawbacks for practical use such as accuracy in angle measurement, cumbersome cable arrangements, and so on. In order to improve these practical drawbacks, a new sensor system was designed, and its availability was evaluated. The results demonstrated that the accuracy of this system showed superior to that of the previous, and this system appears to be a significant means for quantitative assessment of the patient's motion
- 1 August 2006
- Published by Institute of Electrical and Electronics Engineers (IEEE) in 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
- No. 1557170X,p. 5940-5943
Open AccessDevelopment of an Ambulatory Device for Monitoring Posture Change and Walking Speed for Use in Rehabilitation
Monitoring of posture change in sagittal plane and walking speed is important for evaluate the effectiveness of rehabilitation program or brace. We have developed a wearable device for monitoring human activity. However, in the previous system, there still remain several drawbacks for practical use such as accuracy in angle measurement, cumbersome cable arrangements, and so on. In order to improve these practical drawbacks, a new sensor system was designed, and its availability was evaluated. The results demonstrated that the accuracy of this system showed superior to that of the previous, and this system appears to be a significant means for quantitative assessment of the patient's motion
- 1 November 2005
- Published by Elsevier in Journal of Orthopaedic Science
- Vol. 10  (6) , 614-621
Induction of tumor necrosis factor-α in Schwann cells after gradual elongation of rat sciatic nerve
- 1 November 2005
- Published by Elsevier in Journal of Orthopaedic Science
- Vol. 10  (6) , 614-621
Induction of tumor necrosis factor-α in Schwann cells after gradual elongation of rat sciatic nerve